Company Information

  

Address: 4 MENORAT HAMAOR ST.  
City: TEL AVIV 
State:  
Zip Code: 6744832 
Telephone: (888) 776-6804 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

We are a medical device company focusing on the development and commercialization of our proprietary MicroNet(TM) stent platform technology for the treatment of complex vascular and coronary disease. A stent is an expandable "scaffold-like" device, usually constructed of a metallic material, that is inserted into an artery to expand the inside passage and improve blood flow. Our MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Our CGuard(TM) carotid embolic prevention system ("CGuard EPS") combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Our CGuard EPS received CE mark approval in the European Union in March 2013, and we launched its release on a limited basis in October 2014.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20174.55NA0.15
03/20170.26NA3.81
12/2016-5.93NAN/E
09/2016-374.75NAN/E
06/2016-800.00NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.06Total Liab/Total Assets0.57
Net Inc/Total Assets-0.90Total Liab/Inv Cap2.75
Net Inc/Inv Cap-4.33Total Liab/Comm Equity0.04
Pretax Inc/Net Sales-4.47Interest Coverage Ratio-10.73
Net Inc/Net Sales-4.47Curr Debt/Equity0.66
Cash Flow/Net Sales-3.96LTD/EquityNA
SG&A/NetSales3.41Total Debt/Equity0.66
Asset Utilization   Liquidity  
Net Receivables Turnover3.57Quick Ratio1.69
Inventory Turnover2.86Current Ratio1.80
Inventory Day Sales0.01Net Rec/Curr Assets0.06
Net Sales/Work Cap0.50Inv/Curr Assets0.06
Net Sales/PP&E5.00  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 0.64 0.57 0.32 0.47
Cost of Goods Sold 0.49 0.50 0.38 0.44
Selling & Admin Exps 2.04 2.13 1.41 1.78
Operating Income -2.29 -2.40 -1.69 -2.16
Interest Exp 0.00 0.12 0.16 0.20
Pretax Income -2.29 -2.56 -1.86 -2.40
Other Income 0.00 -0.04 -0.02 -0.04
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -2.29 -2.56 -1.86 -2.40

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 6.88 8.57 7.52 10.47
Receivables - Total 0.61 0.66 0.51 0.68
Inventories - Total 0.43 0.33 0.50 0.37
Total Current Assets 7.99 9.58 8.59 11.62
Net Property, Plant & Equipment 0.46 0.50 0.38 0.38
Total Assets 8.91 10.51 9.41 12.46
Liabilities        
Accounts Payable 2.59 2.26 2.10 1.97
Debt in Current Liabilities 0.00 0.00 2.68 3.66
Total Current Liabilities 2.59 2.26 4.78 5.63
Long-Term Debt NA NA 0.00 0.00
Total Liabilities 3.17 2.80 5.37 6.23
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -136.77 -134.47 -131.91 -129.59
Treasury Stock NA NA NA NA
Total Stockholders' Equity 5.74 7.71 4.05 6.23
Total Liabilities and Stockholders' Equity 8.91 10.51 9.41 12.46

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -1.59 -2.76 -1.88 -2.96
Net Cash Provided by Investing Activities -0.04 -0.16 -0.01 -0.03
Net Cash Provided by Financing Activities -0.09 3.98 -1.05 12.58

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20125.35-17.60--
12/20134.87-29.26--
12/20142.82-25.10--
12/20152.31-15.58--
12/20161.89-8.46-5.93
Growth Rates-22.86----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17123724.99




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.